share_log

新里程(002219.SZ):子公司产品拟中选全国中成药采购联盟集中带量采购

New Journey Health Technology Group (002219.SZ): Subsidiary products are planned to be selected for the national Chinese Patent Medicine procurement alliance centralized bulk purchasing.

Zhitong Finance ·  Jan 1 16:18

New Journey Health Technology Group (002219.SZ) announced that its wholly-owned subsidiary, Kangxian Duyimei Biotechnology Co., Ltd. ("Duyimei..."

According to a report from Zhitongcaijing APP, New Journey Health Technology Group (002219.SZ) announced that its wholly-owned subsidiary, Kangxian Duyiwei Biopharmaceutical Co., Ltd. ("Duyiwei Pharmaceutical"), recently participated in the national procurement alliance for Chinese Patent Medicine organized by the National Procurement Office. Based on the announcement from the National Procurement Office regarding the proposed selected results for the national procurement alliance, Duyiwei Pharmaceutical's Duyiwei series products are proposed to be selected for the national procurement alliance for Chinese Patent Medicine.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment